Samtidig anvendelse af CELSENTRI og lægemidler, der hæmmer CYP3A4, kan øge maravirocs plasmakoncentration.
Co-administration of CELSENTRI with medicinal products that inhibit CYP3A4 may increase maraviroc plasma concentrations.